153 related articles for article (PubMed ID: 10580184)
41. Selection of medical treatment in stable angina pectoris: results of the International Multicenter Angina Exercise (IMAGE) Study.
Ardissino D; Savonitto S; Egstrup K; Rasmussen K; Bae EA; Omland T; Schjelderup-Mathiesen PM; Marraccini P; Merlini PA; Wahlqvist I
J Am Coll Cardiol; 1995 Jun; 25(7):1516-21. PubMed ID: 7759701
[TBL] [Abstract][Full Text] [Related]
42. Calcium channel blockade as primary therapy for stable angina pectoris. A double-blind placebo-controlled comparison of verapamil and propranolol.
Subramanian VB; Bowles MJ; Davies AB; Raftery EB
Am J Cardiol; 1982 Nov; 50(5):1158-63. PubMed ID: 6127945
[TBL] [Abstract][Full Text] [Related]
43. Psychosocial variables in relation to various risk factors in patients with stable angina pectoris.
Billing E; Eriksson SV; Hjemdahl P; Rehnqvist N
J Intern Med; 2000 Feb; 247(2):240-8. PubMed ID: 10692087
[TBL] [Abstract][Full Text] [Related]
44. Verapamil and beta-adrenoceptor blockade in the treatment of stable angina pectoris.
Hansen JF; Grytter C; Thomsen S; Sigurd B
Clin Exp Pharmacol Physiol Suppl; 1982; 6():31-41. PubMed ID: 6126287
[TBL] [Abstract][Full Text] [Related]
45. Anti-ischaemic intervention with verapamil in patients recovering from acute myocardial infarction.
Jespersen CM
Eur Heart J; 1995 Aug; 16 Suppl H():13-7. PubMed ID: 8846800
[TBL] [Abstract][Full Text] [Related]
46. Fibrinopeptide A and platelet factor levels in unstable angina pectoris.
Théroux P; Latour JG; Léger-Gauthier C; De Lara J
Circulation; 1987 Jan; 75(1):156-62. PubMed ID: 2947740
[TBL] [Abstract][Full Text] [Related]
47. Verapamil use in patients with cardiovascular disease: an overview of randomized trials.
Pepine CJ; Faich G; Makuch R
Clin Cardiol; 1998 Sep; 21(9):633-41. PubMed ID: 9755379
[TBL] [Abstract][Full Text] [Related]
48. Interleukin-6 and the risk of future cardiovascular events in patients with angina pectoris and/or healed myocardial infarction.
Fisman EZ; Benderly M; Esper RJ; Behar S; Boyko V; Adler Y; Tanne D; Matas Z; Tenenbaum A
Am J Cardiol; 2006 Jul; 98(1):14-8. PubMed ID: 16784912
[TBL] [Abstract][Full Text] [Related]
49. Treatment of hypertension associated with stable angina pectoris: favourable interaction between new metoprolol formulation (OROS) and nifedipine.
Di Somma S; de Divitiis M; Bertocchi F; Carotenuto A; Cudemo G; Petitto M; Napodano M; de Divitiis O
Cardiologia; 1996 Jul; 41(7):635-43. PubMed ID: 8831181
[TBL] [Abstract][Full Text] [Related]
50. [Stable angina pectoris: what is the role of calcium antagonists?].
Tiberti G; Bossi M
G Ital Cardiol; 1997 Oct; 27(10):1062-6. PubMed ID: 9410778
[No Abstract] [Full Text] [Related]
51. Orthostatic response before and after nitroglycerin in metoprolol- and verapamil-treated angina pectoris.
Hyldstrup L; Mogensen NB; Nielsen PE
Acta Med Scand; 1983; 214(2):131-4. PubMed ID: 6414253
[TBL] [Abstract][Full Text] [Related]
52. Serum C-reactive protein and fibrinogen concentrations and self-reported angina pectoris and myocardial infarction: findings from National Health and Nutrition Examination Survey III.
Ford ES; Giles WH
J Clin Epidemiol; 2000 Jan; 53(1):95-102. PubMed ID: 10693909
[TBL] [Abstract][Full Text] [Related]
53. Comparison of oral propranolol and verapamil for combined systemic hypertension and angina pectoris. A placebo-controlled double-blind randomized crossover trial.
Frishman WH; Klein NA; Klein P; Strom JA; Tawil R; Strair R; Wong B; Roth S; LeJemtel TH; Pollack S; Sonnenblick EH
Am J Cardiol; 1982 Nov; 50(5):1164-72. PubMed ID: 6127946
[TBL] [Abstract][Full Text] [Related]
54. Long-term effectiveness of verapamil in stable and unstable angina pectoris. One-year follow-up of patients treated in placebo-controlled double-blind randomized clinical trials.
Scheidt S; Frishman WH; Packer M; Mehta J; Parodi O; Subramanian VB
Am J Cardiol; 1982 Nov; 50(5):1185-90. PubMed ID: 6814226
[TBL] [Abstract][Full Text] [Related]
55. Variability over time of haemostatic and other cardiovascular risk factors in patients suffering from angina pectoris. ECAT Angina Pectoris Study Group.
Pyke SD; Thompson SG; Buchwalsky R; Kienast J
Thromb Haemost; 1993 Nov; 70(5):743-6. PubMed ID: 8128428
[TBL] [Abstract][Full Text] [Related]
56. Rationale for the choice of calcium antagonists in chronic stable angina. An objective double-blind placebo-controlled comparison of nifedipine and verapamil.
Subramanian VB; Bowles MJ; Khurmi NS; Davies AB; Raftery EB
Am J Cardiol; 1982 Nov; 50(5):1173-9. PubMed ID: 6753557
[TBL] [Abstract][Full Text] [Related]
57. Evidence for time-dependent activation of monocytes in the systemic circulation in unstable angina but not in acute myocardial infarction or in stable angina.
Jude B; Agraou B; McFadden EP; Susen S; Bauters C; Lepelley P; Vanhaesbroucke C; Devos P; Cosson A; Asseman P
Circulation; 1994 Oct; 90(4):1662-8. PubMed ID: 7923650
[TBL] [Abstract][Full Text] [Related]
58. Comparison of controlled-onset, extended-release verapamil with amlodipine and amlodipine plus atenolol on exercise performance and ambulatory ischemia in patients with chronic stable angina pectoris.
Frishman WH; Glasser S; Stone P; Deedwania PC; Johnson M; Fakouhi TD
Am J Cardiol; 1999 Feb; 83(4):507-14. PubMed ID: 10073852
[TBL] [Abstract][Full Text] [Related]
59. Modulation of plasma fibrinogen levels by ticlopidine in healthy volunteers and patients with stable angina pectoris.
de Maat MP; Arnold AE; van Buuren S; Wilson JH; Kluft C
Thromb Haemost; 1996 Aug; 76(2):166-70. PubMed ID: 8865524
[TBL] [Abstract][Full Text] [Related]
60. Treatment with verapamil and trandolapril in patients with congestive heart failure and angina pectoris or myocardial infarction. The DAVIT Study Group. Danish Verapamil Infarction Trial.
Hansen JF; Hagerup L; Sigurd B; Pedersen F; Mellemgaard K; Bjergaard OP
Am Heart J; 1997 Aug; 134(2 Pt 2):S48-52. PubMed ID: 9313623
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
